Invesco Mortgage Capital Inc.
NYSE:IVRREIT - Mortgage
+$0.01 today
- Market cap
- $462.26M
- Beta
- 1.55
- P/E (TTM)
- 11.4
- EPS (TTM)
- $0.71
- Dividend yield
- 16.14%
Volume 6.47M
Average 2.24M
IVR Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Invesco Mortgage Capital Inc.NYSE: IVR
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How IVR compares with its peers on the latest reported figures
- IVR's LTM Mar 2026 research & development of $0 is the 2nd highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for IVR, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.31M | — | — | 3.6% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IVR) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for IVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 50.33M | (437.55M) | 189.8M | 329.27M | 339.7M |
| Cost of Revenue | 21.08M | 16.91M | 12.29M | 250.18M | 219.87M |
| Gross Profit | 29.25M | (377.6M) | 177.51M | 79.09M | 119.84M |
| Gross Margin | 58.1% | 86.3% | 93.5% | 24.0% | 35.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 29.23M | 8.42M | 19.73M | 7.15M | 7.27M |
| Operating Expenses | 109.41M | (123.02M) | 19.73M | 19.21M | 18.56M |
| Depreciation & Amortization | (21.38M) | (19.1M) | (9.84M) | 587K | 688K |
| EBITDA | (80.16M) | (331.44M) | 222.84M | 310.38M | 321.14M |
| EBITDA Margin | -159.3% | 75.7% | 117.4% | 94.3% | 94.5% |
| Operating Income | (80.16M) | (331.44M) | 222.84M | 309.79M | 101.28M |
| Operating Margin | -159.3% | 75.7% | 117.4% | 94.1% | 29.8% |
| Interest Income | 169.2M | 194.51M | 277.93M | 286.55M | 295.29M |
| Interest Expense | 0 | 51.56M | 228.23M | 249.72M | 219.87M |
| Other Income / Expenses | (9.84M) | (71.49M) | (238.7M) | (249.91M) | (219.87M) |
| Income Before Tax | (90M) | (402.92M) | (15.86M) | 59.88M | 101.28M |
| Pre-Tax Margin | -178.8% | 92.1% | -8.4% | 18.2% | 29.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (90M) | (402.92M) | (15.86M) | 59.88M | 101.29M |
| Net Margin | -178.8% | 92.1% | -8.4% | 18.2% | 29.8% |
| EPS (Basic) | (4.80) | (12.21) | (0.85) | 0.65 | 1.32 |
| EPS (Diluted) | (4.80) | (12.21) | (0.85) | 0.65 | 1.32 |
| Weighted Avg Shares | 27.6M | 34.15M | 44.07M | 53.48M | 66.31M |
| Weighted Avg Shares (Diluted) | 27.51M | 34.16M | 44.07M | 53.48M | 66.31M |
Invesco Mortgage Capital Inc.
NYSE:IVR
Intrinsic Alpha fair value
Locked
Current Price
$4.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.